Abstract
Demand and deliver: Micelles reversibly crosslinked by boronate esters (see scheme) show in vitro and in vivo stability, and thus minimize premature drug release under physiological conditions. After reaching the tumor sites, drug (stars in scheme) release is activated by cleavage of the boronate esters by the acidic conditions around the tumor or in the target cells, or by the administration of mannitol.
Original language | English (US) |
---|---|
Pages (from-to) | 2864-2869 |
Number of pages | 6 |
Journal | Angewandte Chemie - International Edition |
Volume | 51 |
Issue number | 12 |
DOIs | |
State | Published - Mar 19 2012 |
Keywords
- boronate
- controlled release
- FRET
- micelles
- nanocarriers
ASJC Scopus subject areas
- Chemistry(all)
- Catalysis